learning from experience
Gastro Hep Advances is a new, peer-reviewed journal to be published by the American Gastroenterological Association (AGA)! It aims to provide a broad-scope, online-only, open-access
The infliximab biosimilar CT-P13 subcutaneous (SC) is non-inferior to CT-P13 intravenous (IV) in pharmacokinetics, efficacy, safety, and immunogenicity outcomes of patients with inflammatory bowel diseases
The Spring 2021 Edition of the AGA Clinician’s Companion—the go-to resource for busy clinicians who can’t afford to spend hours sifting through research to find
Recurrent abdominal pain (RAP) in children does not usually persist, but RAP at age 12 years is a risk factor for abdominal pain–related functional gastrointestinal
A new guideline from the American Gastroenterological Association (AGA) provides recommendations on the therapeutic role of intragastric balloons (IGBs)—devices placed endoscopically in the outpatient setting
The Gastroenterology Board of Editors has compiled a list of the Top 20 gastroenterology and hepatology articles published, from any journal, in 2020. The list was created
The Winter edition of the AGA Clinician’s Companion—the go-to resource for busy clinicians who can’t afford to spend hours sifting through research to find clinical value—is out!
The prevalence of metabolic-associated fatty liver disease (MAFLD), detected by transient elastography, is alarmingly high among adolescents, researchers report in the February issue of Clinical Gastroenterology
SARS-CoV-2, by down-regulating intestinal angiotensin converting enzyme 2 (ACE2), alters the intestinal microbiome and promotes leaky gut syndrome, increasing plasma bacterial lipopolysaccharides and/or peptidoglycans to
Of available treatments, topical steroids are most effective at inducing clinical and histologic remission in patients with eosinophilic esophagitis (EoE, in about two-thirds of patients),
© 2020 American Gastroenterological Association
© 2020 American Gastroenterological Association
